First American Financial Corp (NYSE: FAF). Meaningful negative changes in fundamentals have recently occurred: the consensus estimate for December, 2024 decreased significantly, significant quarterly earnings deceleration occurred, and the consensus estimate for December, 2025 decreased […]
FS KKR Capital Corp (NYSE: FSK) has reported E.P.S. of $0.62 for its first fiscal quarter (ending March 31) versus $0.71 for the same period a year ago — a decline of -13%. This result […]
Emerson Electric Co. (NYSE: EMR) has reported earnings for its second fiscal quarter (ending March 31) of $0.87 versus $0.93 for the same period a year ago — a decline of -6%. This performance was […]
On 5/8/24, EchoStar Corp (NASDAQ: SATS) stock suffered a major decline of -11.0%, closing at $15.44. Moreover, this decline was accompanied by exceptionally high trading volume at 234% of normal. Relative to the market the […]
Celanese Corp (NYSE: CE) has reported E.P.S. of $1.11 for its first fiscal quarter (ending March 31) versus $0.87 for the same period a year ago — an increase of 28%. However, this performance was […]
Catalyst Pharmaceutical Inc (NASDAQ: CPRX) has reported E.P.S. of $0.20 for its first fiscal quarter (ending March 31) versus $0.28 for the same period a year ago — a decline of -29%. Relative to the […]
Recent extremely meaningful positive changes in investment behavior have benefitted CNB Financial Corp/PA (NASDAQ: CCNE): positive upside/downside volume developed, and the stock’s recent price rise disrupted its longer term downtrend. CNB Financial Corp/PA (NASDAQ: CCNE) […]
Azenta Inc (NASDAQ: AZTA) has reported E.P.S. of $-2.47 for its second fiscal quarter (ending March 31) versus $-0.03 for the same period a year ago. Relative to the consensus estimate of $0.08, this was […]
Autohome Inc (NYSE: ATHM) has benefited from exceptional positive changes in investment behavior: its shorter term price trend turned up, and the stock’s recent price rise disrupted its longer term downtrend. Recent significant positive changes […]
Assembly Biosciences Inc (NASDAQ: ASMB) has reported E.P.S. of $-1.66 for its first fiscal quarter (ending March 31) versus $-0.37 for the same period a year ago. For the latest four quarters through March 31, […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research